当前位置: X-MOL 学术Nat. Mach. Intell. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data
Nature Machine Intelligence ( IF 18.8 ) Pub Date : 2021-01-04 , DOI: 10.1038/s42256-020-00276-w
Ruoqi Liu 1 , Lai Wei 2 , Ping Zhang 1, 2, 3
Affiliation  

Drug repurposing is an effective strategy to identify new uses for existing drugs, providing the quickest possible transition from bench to bedside. Real-world data, such as electronic health records and insurance claims, provide information on large cohorts of users for many drugs. Here we present an efficient and easily customized framework for generating and testing multiple candidates for drug repurposing using a retrospective analysis of real-world data. Building upon well-established causal inference and deep learning methods, our framework emulates randomized clinical trials for drugs present in a large-scale medical claims database. We demonstrate our framework on a coronary artery disease cohort of millions of patients. We successfully identify drugs and drug combinations that substantially improve the coronary artery disease outcomes but haven’t been indicated for treating coronary artery disease, paving the way for drug repurposing.



中文翻译:


通过模拟真实患者数据的临床试验来重新利用药物的深度学习框架



药物再利用是确定现有药物新用途的有效策略,可以尽可能快地从实验室过渡到临床。真实世界的数据,例如电子健康记录和保险索赔,提供了许多药物的大量用户的信息。在这里,我们提出了一个高效且易于定制的框架,用于使用对现实世界数据的回顾性分析来生成和测试多个候选药物的重新利用。我们的框架建立在完善的因果推理和深度学习方法的基础上,模拟大规模医疗索赔数据库中存在的药物的随机临床试验。我们在数百万冠状动脉疾病患者队列中展示了我们的框架。我们成功地发现了可显着改善冠状动脉疾病结果但尚未被证明可用于治疗冠状动脉疾病的药物和药物组合,这为药物的重新利用铺平了道路。

更新日期:2021-01-04
down
wechat
bug